CONNECT BIOPHARMA HLDGS LTD's ticker is CNTB and the CUSIP is 207523101. A total of 17 filers reported holding CONNECT BIOPHARMA HLDGS LTD in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $468,626 | -30.1% | 603,900 | 0.0% | 0.01% | -42.9% |
Q2 2023 | $670,329 | +16.8% | 603,900 | +5.2% | 0.02% | +16.7% |
Q1 2023 | $574,148 | -99.9% | 574,148 | -6.5% | 0.02% | +20.0% |
Q3 2022 | $792,000,000 | +39.7% | 613,931 | -5.8% | 0.02% | +87.5% |
Q2 2022 | $567,000,000 | – | 651,506 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RA Capital Management | 6,991,003 | $36,004,000 | 0.64% |
Octagon Capital Advisors LP | 279,921 | $1,442,000 | 0.28% |
Altium Capital Management LP | 175,000 | $901,000 | 0.25% |
Deep Track Capital, LP | 647,057 | $3,332,000 | 0.24% |
Ikarian Capital, LLC | 262,237 | $1,350,000 | 0.20% |
Cormorant Asset Management, LP | 200,000 | $1,030,000 | 0.06% |
DLD Asset Management, LP | 121,707 | $627,000 | 0.03% |
RTW INVESTMENTS, LP | 450,000 | $2,318,000 | 0.03% |
ADAGE CAPITAL PARTNERS GP, L.L.C. | 1,250,000 | $6,438,000 | 0.01% |
Chicago Partners Investment Group LLC | 21,892 | $97,000 | 0.01% |